Cell-free DNA depletion via cell-penetrating poly(disulfide)s for rheumatoid arthritis therapy
Source abstract
Abstract
Cell-free DNA (cfDNA)-induced inflammation is linked to various autoimmune diseases, though cfDNA scavenging for cationic polymers has been regarded as an efficient therapeutic pathway. However, most existing cfDNA scavengers have significant cytotoxicity and weakly binds to cfDNA. Here, an advanced cfDNA scavenging strategy via assembly of cfDNA is reported for rheumatoid arthritis (RA) therapy. In this study, we developed a pH-responsive calcium carbonate nanoplatform loaded with low-toxicity guanidinium-containing cell-penetrating poly(disulfide)s (CPDs, LA). The LA could strongly adhere to nucleic acid (NA) and further self-assemble into NA nanospheres. Importantly, the NA nanospheres could be directly delivered into the cell through thiol-mediated uptake, which avoided the activation of the endosomal toll-like receptors (TLRs), thereby inhibited CpG-activated inflammation. As a result, LA@CaCO3 effectively decreased the cfDNA level and alleviated the joint swelling and bone erosion on a collagen-induced arthritis (CIA) rat model of RA. Accordingly, the study proposes an advanced approach to deplete NA for autoimmune disease treatment.
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Immunotherapy and Immune Responses · Extracellular vesicles in disease
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (51)
Show source-provided references
1. Effect of magnetic resonance imaging vs conventional treat-to-target strategies on disease activity remission and radiographic progression in rheumatoid arthritis the IMAGINE-RA randomized clinical trial10.1001/jama.2018.21362 ↗
2. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies10.1093/rheumatology/kep252 ↗
3. The rheumatoid arthritis-associated citrullinome article10.1016/j.chembiol.2018.03.002 ↗
4. Significantly improving the bioefficacy for rheumatoid arthritis with supramolecular nanoformulations10.1002/adma.202100098 ↗
5. Tuned cationic dendronized polymer: molecular scavenger for rheumatoid arthritis treatment10.1002/anie.201813362 ↗
6. Recent advances in nanotheranostics for treat-to-target of rheumatoid arthritis10.1002/adhm.201901541 ↗
7. Cell-free DNA as a biomarker in autoimmune rheumatic diseases10.3389/fimmu.2019.00502 ↗
8. Cationic nanoparticle as an inhibitor of cell-free DNA-induced inflammation10.1038/s41467-018-06603-5 ↗
9. Cationic block copolymer nanoparticles with tunable DNA affinity for treating rheumatoid arthritis10.1002/adfm.202000391 ↗
10. Circulating cell free DNA: a marker to predict the therapeutic response for biological DMARDs in rheumatoid arthritis10.1111/1756-185X.12959 ↗
11. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE10.1038/ni1457 ↗
12. IL-26 Is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation10.1371/annotation/22e63f1f-1a6e-4d53-8d33-06527d9a1dd4 ↗
13. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide10.1038/nature06116 ↗
14. Gene delivery using cell penetrating peptides-zeolitic imidazolate frameworks10.1016/j.micromeso.2020.110173 ↗
15. Cell penetrating peptides: a concise review with emphasis on biomedical applications10.1016/j.biopha.2018.09.097 ↗
16. Cell penetrating peptides, novel vectors for gene therapy10.3390/pharmaceutics12030225 ↗
17. Contrasting roles for actin in the cellular uptake of cell penetrating peptide conjugates
18. Cellular uptake of substrate-initiated cell-penetrating poly(disulfide)s10.1021/ja501581b ↗
19. Carbonized chitosan encapsulated hierarchical porous zeolitic imidazolate frameworks nanoparticles for gene delivery10.1016/j.micromeso.2020.110200 ↗
20. Graphene oxide nanosheets in complex with cell penetrating peptides for oligonucleotides delivery10.1016/j.bbagen.2017.07.002 ↗
21. Magnetic nanoparticle assisted self-assembly of cell penetrating peptides-oligonucleotides complexes for gene delivery10.1038/s41598-017-09803-z ↗
22. Ring tension applied to thiol-mediated cellular uptake10.1002/anie.201502358 ↗
23. Substrate-initiated synthesis of cell-penetrating poly (disulfide)s10.1021/ja311961k ↗
24. E. Bang, G. Gasparini, G. Molinard, N. Sakai, S. Matile, Substrate-initiated synthesis of cell-penetrating poly(disulfide)s, (2013) 2088–2091, doi: 10.1021/ja311961k.10.1021/ja311961k ↗
25. Dual-functional lipid polymeric hybrid pH-responsive nanoparticles decorated with cell penetrating peptide and folate for therapy against rheumatoid arthritis10.1016/j.ejpb.2018.06.020 ↗
26. Targeted and MMP-2/9 responsive peptides for the treatment of rheumatoid arthritis
27. A synthetic cell-penetrating heparin-binding peptide derived from BMP4 with anti-inflammatory and chondrogenic functions for the treatment of arthritis
28. Scavenging nucleic acid debris to combat autoimmunity and infectious disease10.1073/pnas.1607011113 ↗
29. Treatment of severe sepsis with nanoparticulate cell-free DNA scavengers10.1126/sciadv.aay7148 ↗
30. Nucleic acid scavengers inhibit thrombosis without increasing bleeding10.1073/pnas.1204928109 ↗
31. Cell-penetrating peptides and polymers for improved drug delivery10.1002/cnma.202000118 ↗
32. Exploiting cell surface thiols to enhance cellular uptake10.1016/j.tibtech.2011.12.002 ↗
33. Poly(disulfide)s10.1039/c2sc20098h ↗
34. Self-assembled and size-controllable oligonucleotide nanospheres for effective antisense gene delivery through an endocytosis-independent pathway10.1002/anie.201813665 ↗
35. Autoimmunity to type II collagen an experimental model of arthritis10.1084/jem.146.3.857 ↗
36. Polymeric aggregate-embodied hybrid nitric-oxide- scavenging and sequential drug-releasing hydrogel for combinatorial treatment of rheumatoid arthritis
37. A multiparameter approach to monitor disease activity in collagen-induced arthritis
38. Osteoarthritis cartilage histopathology : grading and staging10.1016/j.joca.2005.07.014 ↗
39. A preloaded amorphous calcium carbonate/doxorubicin@silica nanoreactor for pH-responsive delivery of an anticancer drug10.1002/anie.201408510 ↗
40. Synovial ph in rheumatoid knee-joints I. The effect of synovectomy10.3109/17453676908989529 ↗
41. Self-dsDNA in the pathogenesis of systemic lupus erythematosus10.1111/cei.13041 ↗
42. Animal models of rheumatoid arthritis10.1002/eji.200939578 ↗
43. Macrophage migration inhibitory factor : a potential therapeutic target for rheumatoid arthritis10.3904/kjim.2016.098 ↗
44. Mechanisms of Disease : macrophage migration inhibitory factor in SLE, RA and atherosclerosis10.1038/ncprheum0701 ↗
45. Macrophage heterogeneity in the context of rheumatoid arthritis10.1038/nrrheum.2016.91 ↗
46. Macrophage M1/M2 polarization and rheumatoid arthritis: a systematic review
47. Macrophages in rheumatoid arthritis10.1186/ar86 ↗
48. Collagen-induced arthritis as an animal model of rheumatoid cachexia10.1002/jcsm.12280 ↗
49. Utility of animal models for identification of potential therapeutics for rheumatoid arthritis10.1136/ard.2007.076430 ↗
50. Inflammation-targeted celastrol nanodrug attenuates collagen-induced arthritis through nf-κb and notch1 pathways10.1021/acs.nanolett.0c03279 ↗
51. Synergistic oxygen generation and reactive oxygen species scavenging by manganese ferrite/ceria co-decorated nanoparticles for rheumatoid arthritis treatment10.1021/acsnano.8b08785 ↗